Since 1986, penicillin non-susceptible pneumococci (PNSP) have been found in the Czech Republic. As documented by a nationwide study, the proportion of invasive strains with reduced susceptibility to penicillin has fluctuated around 5 % in the past decade. Although the level of resistance to penicillin remains stable, the contribution of different capsular serotypes among the PNSP population varies. Whereas serotype 19A was predominantly associated with penicillin resistance until 1997, serotype 9V became most common among PNSP strains in 1998. In a collection of PNSP strains (n=225) isolated from 2000 to 2002, the most frequent serotype was 9V (n=91, 40?4 %), followed by 19F (n=30, 13?3 %) and 14 (n=25, 11?5 %). PFGE and multilocus sequence typing were used to characterize a set of PNSP of the currently predominant serotypes 9V (n=42), 14 (n=15) was also recovered in the Czech Republic (a single isolate of serotype 19F). These findings confirm the spread of the major penicillin-resistant clones in the Czech Republic.
INTRODUCTION
The global occurrence of penicillin non-susceptible pneumococci (PNSP) has become a serious problem in the treatment of pneumococcal infections. A steady increase in penicillin resistance and the worldwide spread of penicillinresistant clones have been documented for the past two decades (Soares et al., 1993; Baquero, 1995; Coffey et al., 1995) . In 2003, the mean proportion of PNSP isolates reported through the European Antimicrobial Resistance Surveillance System (EARSS) was 10 %; however, a wide variation between countries in the prevalence of PNSP, from <1 % in Estonia and Germany, to 36 % in Romania, has been observed (European Antimicrobial Resistance Surveillance System, 2003) . In the Czech Republic (formerly part of Czechoslovakia until 1992), the first PNSP strains were documented in 1986 (Janečková et al., 1989) . Between 1996 and , the prevalence rates of invasive Streptococcus pneumoniae strains with reduced susceptibility to penicillin oscillated around 5 %, as shown in a nationwide study performed by the National Reference Center for Antibiotics (European Antimicrobial Resistance Surveillance System, 2003; Urbášková et al., 2004) . Out of 666 invasive pneumococci collected during this period, only one isolate was penicillin resistant (MIC¢2 mg ml
21
), and 25 strains tested penicillin-intermediate (MIC 0?125-1?0 mg ml
). From 1992, all consecutive isolates with reduced susceptibility to penicillin from child carriers and children with acute otitis media (AOM) were collected by 31 clinical microbiology laboratories distributed throughout the Czech Republic. From 1992 to 2002, 419 PNSP carriage strains and 236 PNSP strains isolated from middle-ear fluid (MEF) were referred to the National Institute of Public Health. In both of these sets, the proportion of strains highly resistant to penicillin was almost 20 %. Although the level of resistance to penicillin has remained stable in the past decade, changes in the contribution of different capsular serotypes in the PNSP population have been noted. Since its first isolation in 1994, serotype 9V has gradually replaced serotype 19A, which was highly prevalent in the Czech Republic until 1997 (Urbášková & Motlová, 1999 Urbášková et al., 2004) . Among non-invasive PNSP strains, the proportion of serotype 9V increased from 0 % in 1992 to 46?5 % in 2002, while that of serotype 19A decreased from 58?5 % to 16?3 % during the same period. Since 1998, serotype 9V has become predominant among the PNSP serotypes, followed by 19F and 14 (Urbášková et al., 2004) .
Only fragmentary data are available about the genetic background of PNSP strains isolated in the Czech Republic to date. PFGE analysis (Sa Figueiredo et al., 1995) (Table 1 ). The study isolates were randomly selected to be as heterogeneous as possible in terms of susceptibility to antibiotics and geographical origin. Regarding the site of isolation, three sets of PNSP strains from three national surveillance projects were used: 37 carriage strains from nasopharyngeal swabs of healthy children, 22 isolates from MEF of children aged 5 years and younger, and 12 invasive isolates from blood (n=10) and cerebrospinal fluid (n=2) of patients regardless of age.
Antibiotic susceptibility testing. MICs of penicillin, erythromycin, clindamycin, chloramphenicol, tetracycline and trimethoprimsulfamethoxazole were determined by the broth microdilution method, as described by the Clinical and Laboratory Standards Institute (CLSI), formerly the National Committee for Clinical Laboratory Standards. To read the results, the CLSI interpretation criteria were used, except for tetracycline, erythromycin and clindamycin, for which the CLSI intermediate values were considered to constitute resistance (National Committee for Clinical Laboratory Standards, 2000).
Serotyping. The strains were serotyped by Quellung reaction, using type and factor sera provided by the Statens Institut, Copenhagen, Denmark (Sorensen, 1993) .
PFGE. PFGE of chromosomal DNA was performed as previously described (Soares et al., 1993) . Reference strains of epidemic clones Spain Isolates that differed by one to six bands were assigned to different subtypes, and were considered to be members of the same clonal group. *Children aged under 6 years.
DOnly PNSP isolates were collected.
MLST. The sequences of the~450 bp internal fragments from the aroE, gdh, gki, recP, spi, xpt and ddl genes were amplified by PCR using primers, as described by . Alleles and sequence type (STs) were assigned using the data on S. pneumoniae available at the MLST web site (www.mlst.net). Allelic profiles of new STs were electronically submitted to the S. pneumoniae MLST database. Isolates with identical allelic profiles or differing in a single locus were considered as closely related; isolates differing in two loci were assumed to be possibly genetically related.
RESULTS AND DISCUSSION PFGE analysis
Out of the 71 isolates analysed by PFGE, 69 had either identical or related PFGE patterns generated by SmaI digestion ( ). Resistance to these antibiotics was predominantly associated with serotype 14 strains belonging to subtype A5, all isolates of this serotype (n=12) being resistant to erythromycin, clindamycin and chloramphenicol, and five to tetracycline also. In contrast, isolates of serotype 19F belonging to subtype A5 were erythromycin, clindamycin, chloramphenicol and tetracycline susceptible. The PFGE patterns of clone A subtypes were compared with that generated by a Spain 9V -3 isolate. The profiles were identical (subtype A1) or very similar to that of the international Spain 9V -3 clone (maximum difference of six bands), which indicates that the isolates are genotypically identical or related, and can be considered to be members of the same clone. Only two strains of serotype 19F were not related to clone A; moreover, they differed from each other by seven bands in PFGE patterns and were assigned to types C1 and D1. Susceptibility profiles of strains are shown in Table 3 . The comparison of PFGE patterns with that generated by a representative isolate of the Taiwan 19F -14 international clone showed high similarity (four-band difference) of the isolate to type D1, and therefore the relatedness of type D1 to the Taiwan 19F -14 clone; the PFGE pattern of a C1 type isolate differed by seven bands from that of the Taiwan 19F -14 clone, and consequently the isolate was considered to be unrelated to this clone.
MLST analysis
Two representative isolates, if available, of each PFGE subtype of each serotype were chosen for MLST analysis (Table 2) . A total of 24 strains were characterized by MLST. The results of MLST were assumed to be shared by other isolates of the same serotype within a PFGE subtype. Data on serotype, demographic characteristics, antibiotic susceptibility profile and results of PFGE and MLST for individual isolates are given in Table 3 .
Within clone A, three different STs were found: ST 156 (n=15), ST 380 (n=6) and ST 143 (n=1). Allelic profiles identical to that of the international Spain 9V -3 clone (ST 156) were found in all of the analysed isolates of serotype 9V (n=11), and in four out of five isolates of serotype 14, indicating that they were serotype variants of this clone. Both ST 143 and ST 380 are double-locus variants of ST 156; therefore, strains possessing either ST 143 or ST 380 were considered to be possibly related to ST 156. The ST 143 allelic profile was found in a single isolate of serotype 14, which was the only strain of PFGE pattern A6. Isolates of As documented by other authors (Sá-Leão et al., 2001; Gertz et al., 2003; Serrano et al., 2005) , the results obtained by PFGE and MLST may not always overlap. A possible explanation is the difference in discriminatory power between these molecular techniques. In our study, discrepancies were also noted. For example, serotype 19F isolates had PFGE subtype A profiles indistinguishable from those generated by isolates of serotypes 9V and 14, while their allelic profiles differed in two of the seven loci when characterized by MLST. Notwithstanding these variations, all of the isolates belonging to clone A appeared to be genetically related by MLST also, when a less stringent approach (five of seven shared alleles) to define a clonal group (Feil et al., 2004) was applied. On the other hand, strains 4257 and 4401 of serotype 19F had different PFGE types, but shared six of seven loci when characterized by MLST. This could be explained by the classification of isolates into PFGE types being based on a seven-band difference in profiles.
The international spread of a restricted number of multiresistant clones has been documented and the propensity to horizontal gene recombination in these clones has been verified (Coffey et al., , 1999 Munoz et al., 1991; Gasc et al., 1995) . The present study demonstrated the Spain 9V -3 clone (ST 156) to make a major contribution to the PNSP population in the Czech Republic. Apparently, the genetic background of this clone is not restricted to serotype 9V, but is also disseminated within serotype 14 and 19F. In contrast, none of the current isolates of serotype 14 was related to the clone CSR 14 -10 described previously in the former Czechoslovakia.
The genetic background of the Spain 9V -3 clone in serotypes 11A 14, and 19F has been reported previously (Coffey et al., 1999; Enright et al., 1999; Porat et al., 2004) . The ability of pneumococci to undergo capsular transformation could compromise the efficacy of the conjugate pneumococcal vaccine, as the number of serotypes contained in the vaccine is limited (Obaro & Adegbola, 2002; McEllistrem et al., 2003) . The available 7-valent vaccine includes conjugates derived from polysaccharides of types 4, 6B, 9V, 14, 18C, 19F and 23F. Porat et al. (2004) (Shi et al., 1998) . The Taiwan 19F -14 clone is highly predominant among penicillin-resistant strains in far-eastern countries (Song et al., 1997; Shi et al., 1998) ; however, it appears already to have spread intercontinentally, as two penicillin-resistant isolates of serotype 19F with allelic profiles similar to that of Taiwan 19F -14 have been identified in the UK . Richter et al. (2002) have provided evidence of the global spread of this clone, as penicillin-resistant isolates of serotype 19F collected in the USA are grouped into the same cluster with this clone.
Despite stable low rates of resistance to penicillin in the Czech Republic, a significant shift in serotype distribution has been reported (Urbášková & Motlová, 1999; Urbášková et al., 2004) . The shift could be explained by the introduction of the Spain 9V -3 clone into the country from highprevalence western European regions after the political changes in 1989, with the subsequent sharp rise in international travel. Interestingly, in results parallel to those from the Czech Republic, Buxbaum et al. (2004) found serogroup 9 to have become predominant among the penicillin nonsusceptible serogroups in Austria in 1998. In contrast to the Czech Republic, this change was accompanied by a dramatic rise in penicillin resistance, which almost doubled the rate in Austria to nearly 10 %. Due to geographic proximity, resistant strains of serogroup 9 may have been imported into the Czech Republic from Austria; nevertheless, this hypothesis still remains to be confirmed, as detailed information on the genetic background of Austrian strains is not yet available. Moreover, other unknown factors might have been involved in the expansion of the Spain 9V -3 clone, given that it is not clear why other pandemic multiresistant clones did not spread in the country with the same impact.
